Title : Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer.

Pub. Date : 2018 Oct

PMID : 30247247






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVES: Cisplatin and mitomycin C exert high activity towards BRCA1-deficient cells. Cisplatin BRCA1 DNA repair associated Homo sapiens
2 CONCLUSIONS: The combination of cisplatin plus mitomycin C showed promising results in BRCA1-driven OC and therefore deserves further clinical evaluation. Cisplatin BRCA1 DNA repair associated Homo sapiens